About the TCRN

The Translational Cancer Research Network is a collaborative, interactive cancer research consortium based at the Lowy Cancer Research Centre at UNSW Sydney. Launched in 2011, we fund research programs and foster links between cancer researchers, clinicians and services in New South Wales and the Albury-Wodonga region.

The overarching goal of the TCRN is to facilitate the rapid translation of scientific discoveries into clinical policy and practice. Our network is built on a membership base of leading multidisciplinary researchers and clinicians who are passionate about transforming cutting-edge cancer research into enhanced patient outcomes.

Our Research Approach

Research at the TCRN is organised across five flagship areas:

1. Clinical Improvements into Practice

                  a) Enhancing quality of care in surgical oncology

                  b) Broadening the activities of multidisciplinary care groups

                  c) Investigating haematological malignancies and cancer associated thrombosi

         2. Biobanking and Bioinformatics

         3. Continuum of Care (Community-Hospital Practice)

         4. Hereditary Cancer

         5. 2025 Workforce Capacity Building 

Our Structure

The TCRN is funded by the Cancer Institute NSW and operates in collaboration with the South Eastern Sydney Local Health District (SESLHD). We are supported by the following founding member organisations:

• UNSW Australia
• Prince of Wales Hospital
• St George Hospital
• Sutherland Hospital
• Royal Hospital for Women
• Border Medical Oncology Research Unit
• University of Technology Sydney
• Australian Institute of Health Innovation

Key achievements to date (2011-2019)

• Significant growth in membership since 2011 (from 60 members to 350 in 2019)
• High quality research outcomes from members – at least $170M in competitive funding and over 1500 publications
• 50 + research projects and activities led or enabled by the TCRN
• Supported over 50 PhD candidates